Brooktree Capital Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Brooktree Capital Management’s Portfolio CVET Stock Details CVET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-190,339	Closed	-$3.2M	–	39
2022 Q1	$3.2M	Buy	190,339 +120,847	+174%	+$2.11M	2.08%	17
2021 Q4	$1.39M	Sell	69,492 -1,275	-2%	-$24K	0.85%	28
2021 Q3	$1.28M	Hold	70,767	–	–	0.82%	28
2021 Q2	$1.91M	Hold	70,767	–	–	1.23%	25
2021 Q1	$2.12M	Hold	70,767	–	–	1.42%	24
2020 Q4	$2.03M	Sell	70,767 -2,374	-3%	-$64.1K	1.5%	24
2020 Q3	$1.78M	Buy	73,141 +7,205	+11%	+$155K	1.51%	23
2020 Q2	$1.18M	Buy	65,936 +5,780	+10%	+$76K	1.11%	27
2020 Q1	$490K	Buy	+60,156	New	+$687K	0.57%	34

Other funds holding CVET

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

FCM

Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brooktree Capital Management's CVET Position: Q2 2022 in Review

Brooktree Capital Management sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2022, closing a stake of 190,339 shares — an estimated $3.2M sold.

Brooktree Capital Management first reported a position in CVET in Q1 2020 and held it in 9 quarters. The position peaked at $3.2M in Q1 2022. 266 funds tracked by Wall St. Rank hold CVET as of Q2 2022.

Brooktree Capital Management reported no remaining Covetrus, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Brooktree Capital Management sold 190,339 Covetrus, Inc. Common Stock shares in Q2 2022, an estimated $3.2M.
Brooktree Capital Management first reported a position in Covetrus, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
Brooktree Capital Management's Covetrus, Inc. Common Stock position peaked at $3.2M in Q1 2022.
266 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2022.

Based on Brooktree Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.